PBK and lung carcinoma: These findings contribute to the elucidation of the biological mechanisms of lung cancer and offer new biomarkers, and cENPF, AURKA, PBK, and CCNB1 show great potential as specific biomarkers and immunotherapeutic targets for lung cancer.